Studying the Effect of Sertraline in Reducing Aggressive Behavior in Patients with Major Depression

Alireza Farnam ¹, Arezoo MehrAra ¹, Hossein Dadashzadeh ¹, Golamreza Chalabianlou ¹, Salman Safikhanlou ¹ *

Cited by CrossRef: 6

1- Fu R, Hao X, Yu J, Wang D, Zhang J, Yu Z, Gao F, Zhou C. Machine learning-based prediction of sertraline concentration in patients with depression through therapeutic drug monitoring. Front Pharmacol. 2024;15 [Crossref]

2- Halaris A, Sayed A, Hakimi M, Sinacore J. Modulation of the inflammatory response exerts beneficial effects on anger in treatment-resistant bipolar depression. Journal of Affective Disorders Reports. 2023;13:100602 [Crossref]

3- Yang L, Zhang J, Yu J, Yu Z, Hao X, Gao F, Zhou C. Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence. Expert Review of Clinical Pharmacology. 2023;16(8):741 [Crossref]

4- Simutkin G. Anger attacks and «anger disorders»: clinical relevance, problem of classification, comorbidity and therapy (review). VM BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2018;(3):10 [Crossref]

5- Romero-Martínez Á, Murciano-Martí S, Moya-Albiol L. Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review. Behavioral Sciences. 2019;9(5):57 [Crossref]

6- Kwon C, Suh H, Kim J, Chung S. Anti-anger Effects of Herbal Medicine: A Mini-Review of Rat Studies. Chin J Integr Med. 2022;28(3):263 [Crossref]

7- Yao X, Li Y, Yu Z, Mo C, Pan H, Li C. The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: A randomized double-blind placebo-controlled trial. Clinical Neurology and Neurosurgery. 2021;205:106651 [Crossref]